5 years ago

Inotec AMD Raises £7 Million to Expand Wound Healing Solutions

  • Inotec AMD, a UK-based medtech company specializing in chronic wound healing, secured £7 million in funding

  • The round was led by Praetura Ventures with participation from existing investors Amadeus Capital Partners, Puhua Capital, Boundary Capital, and a group of high-net-worth angel investors

  • The company intends to use the funds for growth and expansion into new international markets.

      • ProblemHealthcare

      "Chronic wounds are a major healthcare burden, often leading to prolonged healing times, increased pain, and significant costs. Current treatments are often ineffective, slow, and painful, leaving patients with limited options."

      Solution

      "Inotec AMD's Natrox device uses pure humidified oxygen to treat a range of chronic wounds, including diabetic and venous ulcers, as well as non-healing surgical wounds. This innovative approach offers a faster, more effective, and less painful alternative to traditional treatments, potentially improving patient outcomes and reducing healthcare costs."

      Covered on